CCL5 recruits the TAMs which possess the pro-tumor properties to suppress the anti-tumor immune response and produce vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) to promote angiogenesis, epithelial-to-mesenchymal transition [26]. The gene discussed is CCL5; the disease is neoplasm.